Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-23
1995-06-13
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514365, 514369, 514443, 514457, 546269, 548182, 548203, 549 60, 549283, A61K 3144, C07C31102
Patent
active
054243203
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 5227399 (1993-07-01), Young et al.
Fortin Rejean
Girard Yves
Grimm Erich
Hutchinson John
Scheigetz John
Ivy C. Warren
Merck Frosst Canada Inc.
Owens A. A.
Rose David
Yang Mollie
LandOfFree
Heteroaryl coumarins as inhibitors of leukotriene biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl coumarins as inhibitors of leukotriene biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl coumarins as inhibitors of leukotriene biosynthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1309536